MAPK3 and esophageal squamous cell carcinoma: Consistent with our results, we found that PEDF might stimulate the progression of ESCC via the MAPK/ERK pathway because PEDF can increase the expression of phosphorylated ERK1/2 in esophageal carcinoma cells.